Exhibit 23.3
Re: Consent of GfK (f/k/a Bridgehead International)
To Whom ItMay Concern: |
1 February 2016
Arthur F. Kuhn Vice President Business Support 484.441.1891 arthur.kuhn@gfk.com | We hereby consent to (1) the use of and all references to the name of Bridgehead International in the prospectus included, in the registration statement on Form S-1 of Cancer Prevention Pharmaceuticals, Inc. (the “Company”) and any amendments thereto (the “Registration Statement”); including, but not limited to, the use of the information supplied by us and set forth under the “Prospectus Summary” and “Business” sections; and (2) the filing of this consent as an exhibit to the Registration Statement by the Company for the use of our data and information cited in the above- mentioned sections of the Registration Statement. |
Sincerely, | ||
/s/ Arthur Kuhn | ||
Arthur Kuhn | ||
Vice President, Business Support |
GfK Custom Research, LLC | |
1275 Drummers Lane, Suite 300 | |
Wayne, PA 19087 | |
USA | |
Tel. 484.441.1700 | |
Fax 610.566.9189 |